Preview

Medical Genetics

Advanced search

A case of deletion 8q22.2q22.3 in a child with de novo balanced translocation t(1;6)

https://doi.org/10.25557/2073-7998.2021.04.49-56

Abstract

Identification of the etiopathogenesis of the abnormal phenotype in patients with balanced translocations is current trend in cytogenetic laboratories. The formation of developmental anomalies can be associated with the presence of a cryptic genomic imbalance both at breakpoints and on chromosomes not involved in rearrangements.The aim of this study is diagnostics of genomic imbalance in a patient with balanced translocation and abnormal phenotype. The case was characterized by GTG-banding, chromosomal microarray analysis and FISH diagnosis. We present a new case of deletion 8q22.2-q22.3 in child with balanced translocation t(1;6) and developmental delay/congenital defects due to deletion.

About the Authors

M. E. Minzhenkova
Research Centre for Medical Genetics
Russian Federation


Z. G. Markova
Research Centre for Medical Genetics
Russian Federation


I. V. Anisimova
Research Centre for Medical Genetics
Russian Federation


I. V. Kanivetc
Research Centre for Medical Genetics
Russian Federation


N. V. Shilova
Research Centre for Medical Genetics
Russian Federation


References

1. De Gregori M, Ciccone R, Magini P, et al. Cryptic deletions are a common finding in “balanced” reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet. 2007;44:750-762.

2. Higgins A.W. et al. Characterization of apparently balanced chromosomal rearrangements from the Developmental Genome Anatomy Project. Am J Hum Genet. 2008;82:712-722.

3. Schluth-Bolard С, Delobel B, Damien S et al. Cryptic genomic imbalances in de novo and inherited apparently balanced chromosomal rearrangements: Array CGH study of 47 unrelated. Eur J Med Genet. 2009;52:291-296.

4. Миньженкова М.Е., Маркова Ж.Г., Гусева Д.М. и др. Характеристика геномного дисбаланса у пациентов со сбалансированными хромосомными перестройками и аномалиями развития. Медицинская генетика. 2020; 19(9):18-24.

5. Kuechler A., et al. Five patients with novel overlapping interstitial deletion in 8q22.2-q22.3. Am. J. Med. Genet. 2011; Part A 155:1857-1864.

6. Kuroda Y., et al. Refinement of the deletion in 8q22.2-q22.3: the minimum deletion size at 8q22.3 related to intellectual disability and epilepsy. Am. J. Med. Genet. 2014;Part A: 9999, 1-5.

7. Sinajon P., Gofine T., Ingram J., So J. Microdeletion 8q22.2-q22.3 in a 40-year-old male. Eu J Med Genet. 2015;58(11):569-572.

8. Rincon A., Paez-Rojas P. and Suárez-Obando F. 8q22.2q22.3 Microdeletion Syndrome Associated with Hearing Loss and Intractable Epilepsy. Case Reports in Genetics. 2019;1-6.

9. Marcinkute R., Brazdziunaite D.,Burokiene N. et al. A de novo 8q22.2q22.3 interstitial microdeletion in a girl with developmental delay and congenital defects. Eu J Med Genet. 2015;58(11): E-P11.08:977.

10. Busche A., Tuttelmann F., et al. Clinical and molecular characterization of a novel patient with a 8q22.2q22.3 microdeletion. German society of human genetics 2017 meeting.2017; P-CytoG-127:125.

11. Venegas-Vega C., Guardado M., Juarez E. et al. Clinical and molecular delineation of the emerging 8q22.3 microdeletion syndrome. Eu J Med Genet. 2014;22(1): P08.07-S:149.

12. Paez P., Perdomo S., Rojas X. A first reported case of a microdeletion in 8q22.22q23 in Colombia. Phenotypic and genotyping correlation. Clinical genetics and dysmorphology. 2012;3115W.

13. Swisshelm K., Toomey S., LeRoux J. et al. Co-existence of a complex, three-way translocation with a 4.6 Mb deletion in 8q22.3-8q23.1. American Society of Human Genetics 2016 Annual Meeting. 2016;867F:338.

14. Vlaskamp D.R.M., Callenbach P.M.C., Rump P. et al. Copy number variation in a hospital-based cohort of children with epilepsy. Epilepsia Open. 2017;2(2):244-254.

15. Chen C.-P., Chang T.-Y., Hung F.-Y. et al. Prenatal diagnosis of an 8q22.2-q23.3 deletion associated with bilateral cleft lip and palate and intrauterine growth restriction on fetal ultrasound. Taiwanese Journal of Obstetrics & Gynecology. 2017;56:843-846.

16. Douzgou S., Petersen M. B. Clinical variability of genetic isolates of Cohen syndrome. Clinical Genetics. 2011;79(6):501-506.

17. Wang W,Zhou Z, Zhao W, Huang Y,TangR, YingK,XieY,MaoY. Molecular cloning, mapping and characterization of the human neurocalcin delta gene (NCALD). Biochim Biophys Acta. 2001;1518: 162-167.

18. Tyynismaa H., Ylikallio E., Patel M. et al. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am. J. Hum. Genet. 2009;85(2):290-295.

19. Kellis M. et al. Defining functional DNA elements in the human genome. Proceedings of the National Academy of Sciences: journal. 2014;111(17):6131-6138.


Review

For citations:


Minzhenkova M.E., Markova Z.G., Anisimova I.V., Kanivetc I.V., Shilova N.V. A case of deletion 8q22.2q22.3 in a child with de novo balanced translocation t(1;6). Medical Genetics. 2021;20(4):49-56. (In Russ.) https://doi.org/10.25557/2073-7998.2021.04.49-56

Views: 332


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7998 (Print)